Published in Psychopharmacology (Berl) on May 08, 2010
Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse. PLoS One (2012) 1.21
Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex. J Neurosci Methods (2011) 1.02
A possible link between food and mood: dietary impact on gut microbiota and behavior in BALB/c mice. PLoS One (2014) 0.89
Manual versus automated blood sampling: impact of repeated blood sampling on stress parameters and behavior in male NMRI mice. Lab Anim (2014) 0.88
Use of the light/dark test for anxiety in adult and adolescent male rats. Behav Brain Res (2013) 0.85
Repetitive grooming and sensorimotor abnormalities in an ephrin-A knockout model for Autism Spectrum Disorders. Behav Brain Res (2014) 0.82
Effects of sex and deletion of neuropeptide Y2 receptors from GABAergic neurons on affective and alcohol drinking behaviors in mice. Front Integr Neurosci (2013) 0.82
Effects of the mGluR5 antagonist MPEP on ethanol withdrawal induced anxiety-like syndrome in rats. Behav Brain Funct (2013) 0.82
Are Sema5a mutant mice a good model of autism? A behavioral analysis of sensory systems, emotionality and cognition. Behav Brain Res (2011) 0.81
The influence of sex and estrous cycle on QTL for emotionality and ethanol consumption. Mamm Genome (2011) 0.80
Melanopsin-expressing retinal ganglion cell loss and behavioral analysis in the Thy1-CFP-DBA/2J mouse model of glaucoma. Sci China Life Sci (2013) 0.79
Perinatal vs genetic programming of serotonin states associated with anxiety. Neuropsychopharmacology (2014) 0.78
Exploring Female Mice Interstrain Differences Relevant for Models of Depression. Front Behav Neurosci (2015) 0.76
A fully automated and highly versatile system for testing multi-cognitive functions and recording neuronal activities in rodents. J Vis Exp (2012) 0.76
Role of prefrontal 5-HT in the strain-dependent variation in sign-tracking behavior of C57BL/6 and DBA/2 mice. Psychopharmacology (Berl) (2016) 0.76
Bidirectional Control of Anxiety-Related Behaviors in Mice: Role of Inputs Arising from the Ventral Hippocampus to the Lateral Septum and Medial Prefrontal Cortex. Neuropsychopharmacology (2017) 0.75
Loss of cyclin-dependent kinase 5 from parvalbumin interneurons leads to hyperinhibition, decreased anxiety, and memory impairment. J Neurosci (2015) 0.75
Low-anxiety rat phenotypes can be further reduced through genetic intervention. PLoS One (2013) 0.75
Association of brain immune genes with social behavior of inbred mouse strains. J Neuroinflammation (2015) 0.75
Genetics of mouse behavior: interactions with laboratory environment. Science (1999) 10.74
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods (1985) 9.05
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol (2003) 6.40
Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) (1997) 5.03
The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov (2005) 3.80
Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res (2001) 2.98
A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav (1997) 2.47
Stability of inbred mouse strain differences in behavior and brain size between laboratories and across decades. Proc Natl Acad Sci U S A (2006) 2.31
A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev (2001) 2.18
Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev (2005) 2.17
Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol (1984) 2.04
Effects of repeated maternal separation on anxiety- and depression-related phenotypes in different mouse strains. Neurosci Biobehav Rev (2006) 2.00
Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav Brain Res (2002) 1.97
Animal models of anxiety: do I need multiple tests? Trends Pharmacol Sci (2008) 1.95
Ethologically-based animal models of anxiety disorders. Pharmacol Ther (1990) 1.90
Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav (1994) 1.90
Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav (1995) 1.74
Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology (Berl) (1993) 1.67
Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev (2001) 1.50
Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res (1999) 1.45
Stress and emotionality: a multidimensional and genetic approach. Neurosci Biobehav Rev (1998) 1.45
Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav (1981) 1.40
The use of behavioral test batteries, II: effect of test interval. Physiol Behav (2005) 1.39
Three murine anxiety models: results from multiple inbred strain comparisons. Genes Brain Behav (2007) 1.35
Behavioral alterations induced by repeated testing in C57BL/6J and 129S2/Sv mice: implications for phenotyping screens. Genes Brain Behav (2004) 1.32
Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology (2003) 1.27
Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes. Behav Neurosci (2001) 1.22
Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology (Berl) (2008) 1.18
Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy. Brain Res Rev (2006) 1.17
Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev (1985) 1.14
GABAergic influences on plus-maze behaviour in mice. Psychopharmacology (Berl) (1996) 1.09
Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders. Psychopharmacology (Berl) (2001) 1.08
Common variations in the pretest environment influence genotypic comparisons in models of anxiety. Genes Brain Behav (2005) 1.03
Genetic relationship between anxiety-related and fear-related behaviors in BXD recombinant inbred mice. Behav Pharmacol (2009) 1.01
Genetic animal models of anxiety. Neurogenetics (2003) 1.00
A genetic and multifactorial analysis of anxiety-related behaviours in Lewis and SHR intercrosses. Behav Brain Res (1998) 1.00
Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state? Pharmacol Biochem Behav (1998) 1.00
Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Behav Brain Res (2008) 0.98
Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects. CNS Drug Rev (2007) 0.96
Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology (Berl) (1993) 0.94
Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test. Behav Brain Res (2001) 0.93
Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration. Biochem Pharmacol (1989) 0.93
The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments. Neurosci Biobehav Rev (2002) 0.92
Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline. Genes Brain Behav (2002) 0.92
Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze. Psychopharmacology (Berl) (1991) 0.90
The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen Pharmacol (1995) 0.90
Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies. Psychopharmacology (Berl) (1994) 0.88
Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav (1995) 0.87
Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze. Pharmacol Biochem Behav (1995) 0.87
5HT drugs in animal models of anxiety. Psychopharmacology (Berl) (1993) 0.86
"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology (Berl) (1993) 0.85
Previous experience affects subsequent anxiety-like responses in rats bred for novelty seeking. Behav Neurosci (2007) 0.82
One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology (Berl) (1990) 0.80
Sodium phenobarbitone reverses the anxiogenic effects of compounds acting at three different central sites. Neuropharmacology (1989) 0.79
Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. J Psychiatry Neurosci (1992) 0.79
Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance. Pharmacol Biochem Behav (1999) 0.77
Differences among nine 1,4-benzodiazepines: an ethopharmacological evaluation in mice. Psychopharmacology (Berl) (1989) 0.76
Strain differences in response to a benzodiazepine receptor inverse agonist (FG 7142) in mice. Psychopharmacology (Berl) (1988) 0.75
Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry (2010) 6.15
Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci (2006) 3.92
The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov (2005) 3.80
Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain. J Neurosci (2008) 2.87
Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J Neurosci (2006) 2.68
Why New Zealand must rapidly halve its greenhouse gas emissions. N Z Med J (2009) 2.67
The role of inositol 1,4,5-trisphosphate receptors in Ca(2+) signalling and the generation of arrhythmias in rat atrial myocytes. J Physiol (2002) 2.05
Effects of repeated maternal separation on anxiety- and depression-related phenotypes in different mouse strains. Neurosci Biobehav Rev (2006) 2.00
Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. J Neurosci (2010) 1.99
The evolution of class 1 integrons and the rise of antibiotic resistance. J Bacteriol (2008) 1.83
Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology (2006) 1.58
How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology (2008) 1.56
Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J Cell Biol (2006) 1.52
Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability. J Neurosci (2010) 1.49
Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cereb Cortex (2009) 1.48
Elastohydrodynamic separation of pleural surfaces during breathing. Respir Physiol Neurobiol (2003) 1.48
Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit. Learn Mem (2008) 1.46
Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia. Neuropsychopharmacology (2008) 1.43
Variation in mouse basolateral amygdala volume is associated with differences in stress reactivity and fear learning. Neuropsychopharmacology (2008) 1.43
Ontogeny of fear-, anxiety- and depression-related behavior across adolescence in C57BL/6J mice. Behav Brain Res (2006) 1.37
An investigation of the behavioral actions of ethanol across adolescence in mice. Psychopharmacology (Berl) (2007) 1.36
Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am J Psychiatry (2010) 1.34
The touchscreen operant platform for testing learning and memory in rats and mice. Nat Protoc (2013) 1.31
Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF. Nat Neurosci (2011) 1.30
Chronic alcohol produces neuroadaptations to prime dorsal striatal learning. Proc Natl Acad Sci U S A (2013) 1.30
Genetic and dopaminergic modulation of reversal learning in a touchscreen-based operant procedure for mice. Behav Brain Res (2006) 1.29
50 years of hurdles and hope in anxiolytic drug discovery. Nat Rev Drug Discov (2013) 1.28
Ethanol-related behaviors in mice lacking the NMDA receptor NR2A subunit. Psychopharmacology (Berl) (2006) 1.28
Amygdala FAAH and anandamide: mediating protection and recovery from stress. Trends Pharmacol Sci (2013) 1.27
Lubrication regimes in mesothelial sliding. J Biomech (2004) 1.26
Rescue of impaired fear extinction and normalization of cortico-amygdala circuit dysfunction in a genetic mouse model by dietary zinc restriction. J Neurosci (2010) 1.25
Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brain. Neuropsychopharmacology (2007) 1.25
Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. J Neurosci (2006) 1.21
The touchscreen operant platform for assessing executive function in rats and mice. Nat Protoc (2013) 1.21
Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology (2005) 1.20
Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology (Berl) (2008) 1.18
Ethanol-related behaviors in serotonin transporter knockout mice. Alcohol Clin Exp Res (2006) 1.18
Effect of neonatal handling and paternal care on offspring cognitive development in the monogamous California mouse (Peromyscus californicus). Horm Behav (2004) 1.17
The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psychopharmacology (Berl) (2007) 1.14
Effects of repeated maternal separation on prepulse inhibition of startle across inbred mouse strains. Genes Brain Behav (2006) 1.13
Serotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memory. Proc Natl Acad Sci U S A (2012) 1.12
Age-related changes in visual acuity, learning and memory in C57BL/6J and DBA/2J mice. Neurobiol Aging (2006) 1.12
Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes. Neuropsychopharmacology (2012) 1.11
Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor. Eur J Neurosci (2004) 1.10
GluN2B in corticostriatal circuits governs choice learning and choice shifting. Nat Neurosci (2013) 1.10
Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav Genet (2007) 1.10
Platelets and cardiovascular disease. Eur J Cardiovasc Nurs (2002) 1.10
Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies. Cell Mol Neurobiol (2006) 1.09
RNA sequencing reveals differential expression of mitochondrial and oxidation reduction genes in the long-lived naked mole-rat when compared to mice. PLoS One (2011) 1.08
Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc Natl Acad Sci U S A (2005) 1.08
Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Behav Brain Res (2009) 1.06
Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res (2006) 1.05
Functional roles of NMDA receptor NR2A and NR2B subunits in the acute intoxicating effects of ethanol in mice. Synapse (2005) 1.04
Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization. Psychopharmacology (Berl) (2008) 1.04
Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist. Biol Psychiatry (2008) 1.04
The lonely mouse: verification of a separation-induced model of depression in female mice. Behav Brain Res (2009) 1.03
Chronic swim stress alters sensitivity to acute behavioral effects of ethanol in mice. Physiol Behav (2007) 1.03
Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J Neurosci (2010) 1.02
Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder? Neuropharmacology (2011) 1.02
Genetic relationship between anxiety-related and fear-related behaviors in BXD recombinant inbred mice. Behav Pharmacol (2009) 1.01
Enhanced extinction of aversive memories by high-frequency stimulation of the rat infralimbic cortex. PLoS One (2012) 1.00
Mutilating hand injuries: principles and management. Hand Clin (2003) 1.00
The acute intoxicating effects of ethanol are not dependent on the vasopressin 1a or 1b receptors. Neuropeptides (2006) 1.00
Genetic and structural analysis of the basolateral amygdala complex in BXD recombinant inbred mice. Behav Genet (2006) 0.99
Nest building in nulligravid, primigravid and primiparous C57BL/6J and DBA/2J mice (Mus musculus). Physiol Behav (2002) 0.99
Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav (2005) 0.99
Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells. Circ Res (2005) 0.99
Reward-related behavioral paradigms for addiction research in the mouse: performance of common inbred strains. PLoS One (2011) 0.99
Vertical instability in spondylolisthesis: a traction radiographic assessment technique and the principle of management. Spine (Phila Pa 1976) (2003) 0.98
Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model. Neuropharmacology (2012) 0.98
Comparison of medial preoptic, amygdala, and nucleus accumbens lesions on parental behavior in California mice (Peromyscus californicus). Physiol Behav (2007) 0.98
Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res (2005) 0.97
Effects of Subchronic Phencyclidine (PCP) Treatment on Social Behaviors, and Operant Discrimination and Reversal Learning in C57BL/6J Mice. Front Behav Neurosci (2009) 0.97
HIV-1 strains identified in Brazilian blood donors: significant prevalence of B/F1 recombinants. AIDS Res Hum Retroviruses (2007) 0.96
Effects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stress. Neuropsychopharmacology (2008) 0.95
Role of major NMDA or AMPA receptor subunits in MK-801 potentiation of ethanol intoxication. Alcohol Clin Exp Res (2008) 0.95
A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology (Berl) (2007) 0.94
Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive rats. Behav Pharmacol (2008) 0.94
Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? Neurobiol Dis (2010) 0.94
Vulnerability to lasting anxiogenic effects of brief exposure to predator stimuli: sex, serotonin and other factors-relevance to PTSD. Neurosci Biobehav Rev (2008) 0.94
Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics. Neuroimage (2004) 0.93
Predictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia. Front Neurosci (2010) 0.93
Diabetes impairs cortical plasticity and functional recovery following ischemic stroke. J Neurosci (2012) 0.93
Medial hypothalamic 5-hydroxytryptamine (5-HT)1A receptors regulate neuroendocrine responses to stress and exploratory locomotor activity: application of recombinant adenovirus containing 5-HT1A sequences. J Neurosci (2004) 0.93
A novel role for PSD-95 in mediating ethanol intoxication, drinking and place preference. Addict Biol (2011) 0.93
Learning, memory and search strategies of inbred mouse strains with different visual abilities in the Barnes maze. Behav Brain Res (2010) 0.93
Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice. Learn Mem (2002) 0.91
Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout mice. Neuropeptides (2005) 0.90
What are we measuring when we test strain differences in anxiety in mice? Behav Genet (2013) 0.90
Yohimbine impairs extinction of cocaine-conditioned place preference in an alpha2-adrenergic receptor independent process. Learn Mem (2008) 0.90
Correction of pincer-nail deformities with autograft or homograft dermis: modified surgical technique. J Hand Surg Am (2005) 0.90
Fear extinction deficits following acute stress associate with increased spine density and dendritic retraction in basolateral amygdala neurons. Eur J Neurosci (2013) 0.89
Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice. Neuropharmacology (2011) 0.89
Tumor necrosis factor-like weak inducer of apoptosis attenuates the action of insulin in hepatocytes. Endocrinology (2008) 0.89
All (C57BL/6) Mice are not Created Equal. Front Neurosci (2011) 0.89
Positive association between ethanol consumption and anxiety-related behaviors in two selected rat lines. Alcohol (2007) 0.89
Effects of chronic swim stress on EtOH-related behaviors in C57BL/6J, DBA/2J and BALB/cByJ mice. Behav Brain Res (2007) 0.88
Fear memory impairing effects of systemic treatment with the NMDA NR2B subunit antagonist, Ro 25-6981, in mice: attenuation with ageing. Pharmacol Biochem Behav (2008) 0.88
Dynamic versus static splinting of simple zone V and zone VI extensor tendon repairs: a prospective, randomized, controlled study. Plast Reconstr Surg (2005) 0.88